Cargando…

Positive cfDNA screening results for 22q11.2 deletion syndrome—Clinical and laboratory considerations

Introduction: Non-invasive prenatal screening (NIPS) via cell-free DNA (cfDNA) screens for fetal chromosome disorders using maternal plasma, including 22q11.2 deletion syndrome (22q11.2DS). While it is the commonest microdeletion syndrome and has potential implications for perinatal management, pren...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soster, Erica, Dyr, Brittany, Rafalko, Jill, Almasri, Eyad, Cacheris, Phillip
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036386/ https://www.ncbi.nlm.nih.gov/pubmed/36968594 http://dx.doi.org/10.3389/fgene.2023.1146669

Ejemplares similares

Three years of clinical experience with a genome-wide cfDNA screening test for aneuploidies and copy-number variants
por: Soster, Erica, et al.
Publicado: (2021)

A new era in aneuploidy screening: cfDNA testing in >30,000 multifetal gestations: Experience at one clinical laboratory
por: Dyr, Brittany, et al.
Publicado: (2019)

Prenatal cfDNA Screening for Emanuel Syndrome and Other Unbalanced Products of Conception in Carriers of the Recurrent Balanced Translocation t(11;22): One Laboratory’s Retrospective Experience
por: Soster, Erica, et al.
Publicado: (2023)

Impact of mosaicism ratio on positive predictive value of cfDNA screening
por: Rafalko, Jill M., et al.
Publicado: (2020)

Laboratory performance of genome-wide cfDNA for copy number variants as compared to prenatal microarray
por: Soster, Erica, et al.
Publicado: (2023)

Genome-wide cell-free DNA screening: a focus on copy-number variants
por: Rafalko, Jill, et al.
Publicado: (2021)

Application of mosaicism ratio to multifetal gestations
por: Rafalko, Jill, et al.
Publicado: (2021)

Not all low fetal fraction cell‐free DNA screening failures are at increased risk for aneuploidy
por: Caldwell, Samantha, et al.
Publicado: (2021)

Tonsillectomy in Children with 22q11.2 Deletion Syndrome
por: Arganbright, Jill M., et al.
Publicado: (2022)

Adult Height, 22q11.2 Deletion Extent, and Short Stature in 22q11.2 Deletion Syndrome
por: Heung, Tracy, et al.
Publicado: (2022)

Hematological abnormalities and 22q11.2 deletion syndrome
por: Rosa, Rafael Fabiano Machado, et al.
Publicado: (2011)

Obesity in adults with 22q11.2 deletion syndrome
por: Voll, S, et al.
Publicado: (2016)

Risk of malignancy in 22q11.2 deletion syndrome
por: Stevens, Toer, et al.
Publicado: (2017)

The Genetics and Epigenetics of 22q11.2 Deletion Syndrome
por: Du, Qiumei, et al.
Publicado: (2020)

Complement Activation in 22q11.2 Deletion Syndrome
por: Grinde, Dina, et al.
Publicado: (2020)

Laryngeal web with 22q11.2 deletion syndrome
por: Abe, Yasuhiro, et al.
Publicado: (2022)

Prenatal Screening and Diagnostic Considerations for 22q11.2 Microdeletions
por: Blagowidow, Natalie, et al.
Publicado: (2023)

Microfluidic Technologies for cfDNA Isolation and Analysis
por: Xu, Zheyun, et al.
Publicado: (2019)

Important Consideration in Choosing Antipsychotics in the Treatment of Patients with 22q11.2 Deletion Syndrome: Risk of Convulsion
por: Choi, Seo-Hyun, et al.
Publicado: (2020)

Shyness discriminates between children with 22q11.2 deletion syndrome and Williams syndrome and predicts emergence of psychosis in 22q11.2 deletion syndrome
por: Schonherz, Yael, et al.
Publicado: (2014)

Evaluation of 22q11.2 deletion in Cleft Palate patients
por: Prabodha, L. B. Lahiru, et al.
Publicado: (2012)

Genotype-phenotype correlation in 22q11.2 deletion syndrome
por: Michaelovsky, Elena, et al.
Publicado: (2012)

Psychopathology and cognition in children with 22q11.2 deletion syndrome
por: Niarchou, Maria, et al.
Publicado: (2014)

Otologic and audiologic findings in 22q11.2 deletion syndrome
por: Verheij, E., et al.
Publicado: (2016)

Psychiatric Disorders Associated with 22q11.2 Deletion Syndrome
por: Gambini, Orsola
Publicado: (2016)

Disrupted anatomic networks in the 22q11.2 deletion syndrome
por: Schmitt, J. Eric, et al.
Publicado: (2016)

Visual processing deficits in 22q11.2 Deletion Syndrome
por: Biria, Marjan, et al.
Publicado: (2017)

Clinical variability of chromosome 22q11.2 deletion syndrome
por: Boyarchuk, Oksana, et al.
Publicado: (2017)

22q11.2 Deletion Syndrome–Associated Parkinson's Disease
por: Boot, Erik, et al.
Publicado: (2018)

Dopaminergic neurons in chromosome 22q11.2 deletion syndrome
por: Inoue, Haruhisa
Publicado: (2021)

22q11.2 Deletion and Duplication Syndromes and COVID-19
por: Crowley, T. Blaine, et al.
Publicado: (2022)

Deletion Syndrome 22q11.2: A Systematic Review
por: Cortés-Martín, Jonathan, et al.
Publicado: (2022)

Clinical management of psychosis in 22q11.2 deletion syndrome
por: Iftimovici, Anton, et al.
Publicado: (2022)

Reproductive Outcomes in Adults with 22q11.2 Deletion Syndrome
por: Palmer, Lisa D., et al.
Publicado: (2022)

Combinatorial Power of cfDNA, CTCs and EVs in Oncology
por: Keup, Corinna, et al.
Publicado: (2022)

cfDNA Sequencing: Technological Approaches and Bioinformatic Issues
por: Bohers, Elodie, et al.
Publicado: (2021)

Plasma cfDNA predictors of established bacteraemic infection
por: Urosevic, Nadezda, et al.
Publicado: (2022)

Plasma cfDNA for the Diagnosis and Prognosis of Colorectal Cancer
por: Wu, Zhiwei, et al.
Publicado: (2022)

Identification of osimertinib-resistant EGFR L792 mutations by cfDNA sequencing: oncogenic activity assessment and prevalence in large cfDNA cohort
por: Fairclough, Stephen R., et al.
Publicado: (2019)

The internet is parents' main source of information about psychiatric manifestations of 22q11.2 deletion syndrome (22q11.2DS)()
por: van den Bree, Marianne B.M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ld8d0nrml6usuqq015olavu3td